New scan may predict brain tumor treatment success
NCT ID NCT06855628
First seen Nov 01, 2025 · Last updated Apr 29, 2026 · Updated 25 times
Summary
This study looks at whether a special imaging technique (DMI) can help predict how well a new drug (BPM31510) works in people with glioblastoma, a serious brain cancer. About 10 participants will receive the drug alongside standard treatment and undergo imaging scans. The goal is to see if the scan can forecast progression-free survival and overall survival.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLIOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Stanford University
Palo Alto, California, 94305, United States
Conditions
Explore the condition pages connected to this study.